Catalyst Wire Dossier Catalyst Wire Dossier

Runcaciguat

runcaciguat · Bayer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Runcaciguat, covering 2023-04-04 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Non-proliferative Diabetic Retinopathy Treated With Runcaciguat [Phase 2]

See pricing